HCV eradication by DAA improves glucose tolerance and reduces post-load insulin resistance in cirrhotic patients with genotype 1. Issue 1 (February 2018) - Salomone, F.; Catania, M.; Bertino, G.; Godos, J.; Magrì, G.; Li Volti, G.; Montineri, A.